TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $208 | -2.8% | 15 | 0.0% | 0.00% | – |
| Q4 2023 | $214 | -7.8% | 15 | 0.0% | 0.00% | – |
| Q3 2023 | $232 | -1.7% | 15 | 0.0% | 0.00% | – |
| Q2 2023 | $236 | -4.5% | 15 | 0.0% | 0.00% | – |
| Q1 2023 | $247 | +5.6% | 15 | 0.0% | 0.00% | – |
| Q4 2022 | $234 | -76.6% | 15 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 15 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Y.D. More Investments Ltd | 1,498,811 | $24,700,380 | 5.57% |
| TFG Asset Management GP Ltd | 1,903,662 | $31,372,350 | 4.20% |
| Clean Yield Group | 542,342 | $8,937,796 | 3.81% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,467,952 | $24,192 | 3.67% |
| Mondrian Investment Partners LTD | 4,081,715 | $67,266,663 | 1.48% |
| Sippican Capital Advisors | 82,235 | $1,355,233 | 1.30% |
| Psagot Value Holdings Ltd. / (Israel) | 174,300 | $2,830 | 1.18% |
| Clal Insurance Enterprises Holdings Ltd | 4,365,500 | $71,943 | 1.08% |
| Legacy Wealth Asset Management, LLC | 123,303 | $2,032,033 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 1,817,972 | $29,960,175 | 0.64% |